A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 1, 2005, Pages 80-83

  Nassiri Kashani, M ^a   Firooz, A ^a   Khamesipour, A ^a   Mojtahed, F ^a   Nilforoushzadeh, M ^b   Hejazi, H ^b   Bouzari, N ^a   Dowlati, Y ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical trial; Leishmania major; Leishmaniasis

Indexed keywords

ITRACONAZOLE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ENDEMIC DISEASE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LEISHMANIA MAJOR; MAJOR CLINICAL STUDY; PARASITOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKIN LEISHMANIASIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ITRACONAZOLE; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 13944255148     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01133.x     Document Type: Article

References (18)

1. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol 1996; 14: 417-423.
2. Dowlati Y. Cutaneous leishmaniasis. Clin Dermatol 1996; 14: 425-431.
3. Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermarol 1996; 14: 513-518.
4. Hart DT, Lauwers WJ, Willemsens G et al. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Mol Biochem Parasitol 1989; 33: 123-134.
5. Navin TR, Arana BA, Arana FE, Berman JD, Chajon JF. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165: 528-534.
6. Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990; 89: 147-155.
7. Alrajhi AA, Ibrahim EA, De EB et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002, 346: 891-895.
8. Dogra J. Cutaneous leishmaniasis in India: evaluation of oral drugs (dapsone versus itraconazole). Eur J Dermatol 1992; 8: 568-569.
9. Al-Fouzan AS, Al Saleh QA, Najem NM, Rostom AI. Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole. Int J Dermatol 1991; 30: 519-521.
10. Momeni AZ, Jalayer T, Emamjomeh M et al. Treatment of cutaneous leishmaniasis with itraconazole: randomized double-blind study. Arch Dermatol 1996; 132: 784-786.
11. Hejazi H, Nasrifar P, Jamali S, Jahangirnezhad A, Khamesipour A. Identification of Leishmania species using monoclonal antibodies in Esfahan. Iranian J Dermatol 2000; 4: 7-11 (In Farsi).
12. Kubba R, Al-Gindan Y, El-Hassan AM, Omer AHS. Ketoconazole in cutaneous leishmaniasis: results of a pilot study. Saudi Med J 1986; 7: 596-604.
13. Weinrauch L, Livshin R, Even-Paz Z, El-On J. Efficacy of ketoconazole in cutaneous leishmaniasis. Arch Dermatol Res 1983; 275: 353-354.
14. Alsaleh QA, Dvorak R, Nanda A. Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait. Int J Dermatol 1995; 34 495-497.
15. Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987; 9 (Suppl. 1): S57-S63.
16. Van Den Enden E, Van Gompel A, Stevens A et al. Treatment of cutaneous leishmaniasis with oral itraconazole. Int J Dermatol 1994; 33: 285-286.
17. De Beule K, Cauwenberg G. Treatment of cutaneous leishmaniasis with ketoconazole and itraconazole. In: Rubinstein E, Adam D, editors. Recent Advances in Chemotherapy. Lewin-Epstein, Ltd, Jerusalem, 1989: 612.1-612.2.
18. Hafez J, Al-Taqui M, Fowzy M et al. Cutaneous leishmaniasis in Kuwait: part II. Therapeutic trial of rifampicin and pentostam. Arab J Med 1985; 4: 20-22.